Research notes from Dr. Miyamoto

We are pleased to let you hear Dr. Sayuri Myiamoto present her preliminary work, listen to the video. There is a lot more to learn, and her lab is working on the next steps. She is publishing her novel data, we will let you know when the manuscript finishes and in the review process. A part of her work is testing ALS patients for the novel lipid markers they have identified. Although the lipid marker isn't specific for ALS, once ALS is diagnosed, it may be a prognostic marker.


We are hopeful that finding treatments that can modify (increase) this marker in a person the drugs would bring benefit to ALS patients, perhaps slowing disease progression.

4 views0 comments

Recent Posts

See All

We are pleased to announce that Dr. Steve Pelech, Kinexus Bioinformatics Corp, completed a long time goal with funding help from NDR. Steve developed a suite of 230 rabbit polyclonal, affinity-purifie

We welcome Dr. Anthony Akkari, newest member to our scientific discussion group at NDR. He wears three professional hats. Dr. Akkari is a professor at Murdoch University (Perth, Australia), he heads t